PELL Bio-Med Technology Co Ltd

As of June 30, 2026, PELL Bio-Med Technology Co Ltd carries a market capitalization of 2.85B, placing it among publicly traded companies globally. Its enterprise value stands at 1.07B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, PELL Bio-Med Technology Co Ltd has 65.55M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, PELL Bio-Med Technology Co Ltd maintains a current ratio of 10.07, meaning it holds 10.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, PELL Bio-Med Technology Co Ltd's stock has gained approximately 114.21% over the past 52 weeks. The 50-day moving average sits at 50.11, while the 200-day moving average is 37.12.

As of June 30, 2026, PELL Bio-Med Technology Co Ltd holds 2.27B in cash and equivalents against 231.52M in total debt, resulting in a net debt position of -1.75B. Total book value stands at 2.57B, with working capital of 2.11B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

PELL Bio-Med Technology Co Ltd's most recent stock split took place on September 7, 2026 with a 1:20 split ratio.